[13-9] Confronting the threat of arbovirus infections and their vectors

2024年8月30日(金) 09:45 〜 11:45 Room J

座長: Kyoko Sawabe (National Institute of Infectious diseases), Chizu Sanjoba (The University of Tokyo)

+全てマイスケジュールに登録

09:45 〜 10:00

[13-9-01] Understanding the Dynamics of Dengue Fever Outbreaks: An Analysis of Travel History, Vector Density, and Transmission in Tainan City, Taiwan.

*Ting-Chun Shih¹, Yen-Chieh Chiu¹, Hui-Ching Cheng¹, Yung-Cheng Yang¹, Hsiang-Yu Hsiao¹, Hsiao-Mei Lin^2,3, Shin-Bin Su^2,3, Wu-Chun Tu^1,4, Chin-Gi Huang¹ (1. National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes (Taiwan), 2. Public Health Bureau, Tainan City Government (Taiwan), 3. Tainan City Government Dengue Prevention and Control Center (Taiwan), 4. Department of Entomology, National Chung Hsing University (Taiwan))

10:00 〜 10:15

[13-9-02] Vector and host diversity shape West Nile virus transmission in urban green spaces along an urban-rural transect

*Christopher M. Stone¹, Jiayue Yan¹, Chang-Hyun Kim¹, Michael Ward¹, Andrew Mackay¹ (1. University of Illinois Urbana-Champaign (United States of America))

10:15 〜 10:30

[13-9-03] Overwintering of Japanese encephalitis virus and its vector mosquito Culex tritaeniorhynchus Giles in Japan

*Ryusei Kuwata¹, Makoto Takeishi¹, Toshiya Kimura, Yuki Inoue, Hideaki Ohae, Itaru Tokui, Kenzo Yonemitsu, Shohei Minami, Yudai Kuroda, Kango Tatemoto, Milagros Virhuez Mendoza, Keita Ishijima, Yutaka Terada, Hiroshi Shimoda, Haruhiko Isawa, Ken Maeda, Yasuhiro Yoshikawa¹ (1. Okayama University of Science (Japan))

10:30 〜 10:45

[13-9-04] Potential for expanding exposure risks to Ixodes spp. and their associated pathogens in Japan based on spatial modeling approaches

*Patrick Kelly¹, Shuhei Ito², Yoshikazu Nakayama², Andreas Pilz³, Julie Davis⁴, James Stark¹, Harish Madhava⁵, Jennifer Moisi⁶ (1. Pfizer Biopharma Group (United States of America), 2. Pfizer Biopharma Group (Japan), 3. Pfizer Biopharma Group (Austria), 4. Clarivate Analytics (United States of America), 5. Pfizer Biopharma Group (UK), 6. Pfizer Biopharma Group (France))

10:45 〜 11:00

[13-9-05] Tick-borne viruses in Asia as a threat to emerging human infectious diseases

*Daisuke Kobayashi¹ (1. National Institute of Infectious Diseases (Japan))

11:00 〜 11:15

[13-9-06] Blowflies are the potential vector for transmission of the HPAI virus

*Ryosuke Fujita¹, Takuji Tachi¹, Masato Hino¹, Kosuke Nagata², Masahiro Saiki¹ (1. Kyushu University (Japan), 2. Hokkaido Research Organization (Japan))

11:15 〜 11:30

[13-9-07] Impact of biting midges as vectors of livestock diseases

*Tohru Yanase¹ (1. National Institute of Animal Health, NARO (Japan))

11:30 〜 11:45

[13-9-08] Electropenetrography: A new tool to study probing and ingestion behaviors of biting midges

*Anastasia Cooper¹, Kristopher Silver¹, Dana Mitzel² (1. Kansas State University (United States of America), 2. National Bio and Agro-Defense Facility (United States of America))

セッション情報